Shalini Sharp

Insider Reports History

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Signature
/s/ Ran Xiao, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shalini Sharp:

Insider Reports Filed by Shalini Sharp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SEPN Septerna, Inc. Oct 24, 2024 0 $0 3 Oct 24, 2024 Director
BGNE BeiGene, Ltd. Sep 30, 2024 2 $0 4 Oct 2, 2024 Director
BGNE BeiGene, Ltd. Sep 27, 2024 0 $0 3 Oct 2, 2024 Director
OGN Organon & Co. Jun 7, 2024 1 $200K 4 Jun 11, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC May 22, 2024 2 $0 4 May 23, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2024 3 -$157K 4 May 21, 2024 Director
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 4 $0 4 Jan 23, 2024 Director
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $400K 4 Jan 3, 2024 Director
OGN Organon & Co. Jun 9, 2023 1 $200K 4 Jun 13, 2023 Director
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2023 2 $0 4 May 19, 2023 Director
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 Director
OGN Organon & Co. Jun 10, 2022 1 $200K 4 Jun 14, 2022 Director
STRO SUTRO BIOPHARMA, INC. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director
NBIX NEUROCRINE BIOSCIENCES INC May 18, 2022 1 $0 4 May 20, 2022 Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 2 $0 4 Jan 18, 2022 Director
OGN Organon & Co. Jun 4, 2021 1 $327K 4 Jun 8, 2021 Director
STRO SUTRO BIOPHARMA, INC. Jun 3, 2021 1 $0 4 Jun 7, 2021 Director
NBIX NEUROCRINE BIOSCIENCES INC May 19, 2021 1 $0 4 May 20, 2021 Director
OGN Organon & Co. May 14, 2021 0 $0 3 May 17, 2021 Director
DTIL PRECISION BIOSCIENCES INC May 10, 2021 1 $0 4 May 12, 2021 Director